Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2015-05-22 20:35 2015-05-21 OFIX Orthofix Medical Inc. SCOON DAVEY Director SELL $32.38 5,709 $184,857 10,917
2015-05-22 16:27 2015-04-24 LMAT LEMAITRE VASCULAR INC LeMaitre Cornelia W Director SELL $8.66 7,900 $68,416 328,740
2015-05-23 00:01 2015-05-22 BDX BECTON DICKINSON & CO Polen Thomas E Jr Officer OPT+S $142.56 3,882 $553,409 4,939
2015-05-22 17:04 2015-05-21 WST WEST PHARMACEUTICAL SERVICES INC Green Eric Mark Officer BUY $54.89 18,300 $1,004,441 18,300
2015-05-21 20:48 2015-05-19 TTOO T2 Biosystems, Inc. Elsbree David B Director BUY $16.47 6,250 $102,940 4,200
2015-05-21 20:33 2015-05-20 HAE HAEMONETICS CORP LINDOP CHRISTOPHER J Officer OPT+S $41.65 4,902 $204,172 38,188
2015-05-22 02:57 2015-05-19 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer OPT+S $69.58 17,500 $1,217,564 430,626
2015-05-21 20:57 2015-05-20 BDX BECTON DICKINSON & CO Tharby Linda M Officer OPT+S $142.02 6,069 $861,894 6,697
2015-05-21 17:44 2015-05-20 BDX BECTON DICKINSON & CO KOZY WILLIAM A Officer OPT+S $142.00 10,326 $1,466,292 73,708
2015-05-20 23:22 2015-05-18 LMAT LEMAITRE VASCULAR INC Gebauer Peter R Officer OPT+S $10.12 10,000 $101,229 41,307
2015-05-21 03:34 2015-05-18 DXCM DEXCOM INC MOY JEFFREY Officer SELL $69.20 15,586 $1,078,551 122,922
2015-05-21 03:32 2015-05-18 DXCM DEXCOM INC Balo Andrew K Officer OPT+S $68.46 7,500 $513,470 179,741
2015-05-21 03:31 2015-05-18 DXCM DEXCOM INC ROPER JESS Officer OPT+S $69.27 7,000 $484,880 108,483
2015-05-20 23:18 2015-05-18 BDX BECTON DICKINSON & CO KOZY WILLIAM A Officer OPT+S $142.01 10,435 $1,481,845 73,708
2015-05-20 02:34 2015-05-15 RMD RESMED INC Farrell Michael J. Officer OPT+S $56.62 5,975 $338,305 122,440
2015-05-19 23:11 2015-05-15 MDXG MIMEDX GROUP, INC. Taylor William Charles Director, Officer OPT+S $10.01 150,000 $1,500,885 432,985
2015-05-20 02:56 2015-05-06 ATEC Alphatec Holdings, Inc. Asai Mitsuo Officer BUY $1.35 20,000 $27,000 226,610
2015-05-20 02:56 2015-05-05 ATEC Alphatec Holdings, Inc. Williams Donald Allen Director BUY $1.32 5,000 $6,600 36,034
2015-05-20 00:43 2015-05-15 INFU InfuSystem Holdings, Inc Steen Eric K Director, Officer BUY $3.08 5,682 $17,487 138,913
2015-05-19 23:19 2015-05-18 BSX BOSTON SCIENTIFIC CORP MARIO ERNEST Director SELL $18.09 50,000 $904,630 211,032
2015-05-20 00:53 2015-05-15 LMAT LEMAITRE VASCULAR INC LeMaitre George W Director, Officer, 10% owner SELL $10.01 20,132 $201,463 3,940,044
2015-05-20 00:49 2015-05-15 LMAT LEMAITRE VASCULAR INC Kamke Trent G Officer OPT+S $10.03 5,705 $57,238 9,165
2015-05-19 23:19 2015-05-18 BSX BOSTON SCIENTIFIC CORP JOHNSON KRISTINA M Director SELL $18.10 16,301 $295,022 0
2015-05-19 21:48 2015-05-18 BDX BECTON DICKINSON & CO Lim James C Officer OPT+S $141.80 3,604 $511,047 11,278
2015-05-19 16:39 2015-05-18 BDX BECTON DICKINSON & CO Mecklenburg Gary A Director SELL $141.60 2,160 $305,856 20,965
2015-05-19 16:38 2015-05-18 BDX BECTON DICKINSON & CO SCOTT BERTRAM L Director SELL $141.74 2,160 $306,158 22,416
2015-05-19 17:08 2015-05-18 WST WEST PHARMACEUTICAL SERVICES INC Flynn Karen Officer OPT+S $55.00 1,909 $104,995 24,610
2015-05-18 18:34 2015-05-15 MMM 3M CO Roman Michael F Officer OPT+S $162.73 6,900 $1,122,857 5,574
2015-05-18 22:02 2015-05-04 TTOO T2 Biosystems, Inc. Lowery Thomas J. Officer OPT+S $16.00 1,000 $16,000 5,882
2015-05-19 00:12 2015-05-15 INFU InfuSystem Holdings, Inc Foster Jonathan P. Officer BUY $3.07 4,270 $13,109 22,603
2015-05-18 23:18 2015-05-14 ATRC AtriCure, Inc. Krell Elizabeth D Director SELL $21.77 10,000 $217,700 7,162
2015-05-19 00:20 2015-05-14 CTSO Cytosorbents Corp Kraus Al Director OPT+S $6.00 10,000 $59,996 55,746
2015-05-19 00:00 2015-05-15 PODD INSULET CORP Scannell Timothy J Director BUY $27.05 3,500 $94,675 12,120
2015-05-19 03:42 2015-05-14 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer OPT+S $69.24 82,500 $5,712,341 507,139
2015-05-18 19:16 2015-05-14 WST WEST PHARMACEUTICAL SERVICES INC MOREL DONALD E JR Officer SELL $54.29 20,000 $1,085,708 794,187
2015-05-15 15:29 2015-05-14 BSX BOSTON SCIENTIFIC CORP Sununu John E Director SELL $17.87 10,000 $178,700 10,650
2015-05-15 23:45 2015-05-15 BDX BECTON DICKINSON & CO Conroy Alexandre Officer OPT+S $141.37 1,291 $182,509 17,175
2015-05-15 00:08 2015-05-12 NEPH NEPHROS INC PERSEN MALCOLM C Director BUY $0.00 31,160 $0 31,160
2015-05-15 00:05 2015-05-12 NEPH NEPHROS INC ROSENBERG MATTHEW Director BUY $0.00 200,000 $0 789,695
2015-05-15 01:11 2015-05-13 BDX BECTON DICKINSON & CO SHERMAN JEFFREY S Officer OPT+S $138.40 10,983 $1,520,047 26,086
2015-05-13 23:27 2015-05-11 PODD INSULET CORP Diehl R Anthony Officer OPT+S $26.63 12,500 $332,875 30,837
2015-05-14 03:54 2015-05-11 DXCM DEXCOM INC MOY JEFFREY Officer SELL $67.84 20,303 $1,377,370 138,508
2015-05-14 03:24 2015-05-11 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer OPT+S $68.65 3,517 $241,441 430,626
2015-05-14 00:40 2015-05-11 NUOT Nuo Therapeutics, Inc. Aldagen Holdings, LLC 10% owner SELL $0.27 50,000 $13,500 13,139,215
2015-05-12 23:09 2015-05-11 BSX BOSTON SCIENTIFIC CORP Sorenson John Bradley Officer OPT+S $17.49 8,735 $152,808 13,487
2015-05-12 23:53 2015-05-08 IART INTEGRA LIFESCIENCES HOLDINGS CORP LEONETTI DEBORAH A Officer SELL $64.82 2,000 $129,640 8,715
2015-05-13 03:40 2015-05-08 DXCM DEXCOM INC VALDES JORGE A Officer OPT+S $68.27 30,878 $2,108,128 18,017
2015-05-13 03:39 2015-05-08 DXCM DEXCOM INC LISTER JOHN Officer OPT+S $68.49 4,173 $285,819 129,317
2015-05-13 00:05 2015-05-11 BDX BECTON DICKINSON & CO Hurwitz Jerome V Officer OPT+S $141.43 1,197 $169,292 4,866
2015-05-11 22:56 2015-05-08 TTOO T2 Biosystems, Inc. Pfaller Michael A. Officer OPT+S $16.31 15,440 $251,826 0
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.